About Us

Mission Statement

A resource for healthcare providers established by The Endocrine Society.

Our mission:

  • Engage primary care physicians in pathophysiology-based clinical decision making through an interactive educational format that stimulates debate and encourages physicians to incorporate the new science into their treatment regimens for patients with type 2 diabetes.  


In September, 2010, The Endocrine Society launched BetacellsinDiabetes.org based on recommendations from a meeting which brought together basic researchers, clinical endocrinologists, and primary care physicians (PCPs) to discuss the need to improve understanding of the role of beta cells as key drivers in the natural history of T2DM. The hope is that this effort will aid primary care physicians in the interpretation of concepts of disease pathogenesis, such as beta cell dysfunction, and improve medical decision-making in T2DM.


BetacellsinDiabetes.org is supported by an educational grant from Novo Nordisk, Inc and contributions from Lilly USA, LLC (for further information concerning Lilly grant funding (visit www.lillygrantoffice.com) and Merck & Co., Inc.